报价延迟最少15分钟:2025/11/15 01:10 EST
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
14.4 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-1.14/-1.66
|
|
企业价值
965.78M
|
| 资产负债 |
|
每股账面净值
1.37
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟：2025/11/15 01:10 EST
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. |
